Multiplexing Technology Firm Genalyte Raises $11.8M in Series B Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genalyte today announced the completion of a Series B financing that raised $11.8 million.

The funds will primarily go toward commercializing its Maverick platform and highly multiplexed panels for autoimmune and immunoassay applications, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.